Cargando…
Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go
Puerarin (Pue), known as a phytoestrogen, has salient bioactivities and is promising against cardiovascular diseases. This article summarizes the underlying molecular mechanisms of Pue in treating cardiovascular diseases, especially regulating the intracellular signal transduction, influencing ion c...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476793/ https://www.ncbi.nlm.nih.gov/pubmed/36117660 http://dx.doi.org/10.1016/j.chmed.2021.12.003 |
_version_ | 1784790216495595520 |
---|---|
author | Qin, Weida Guo, Jianghong Gou, Wenfeng Wu, Shaohua Guo, Na Zhao, Yuping Hou, Wenbin |
author_facet | Qin, Weida Guo, Jianghong Gou, Wenfeng Wu, Shaohua Guo, Na Zhao, Yuping Hou, Wenbin |
author_sort | Qin, Weida |
collection | PubMed |
description | Puerarin (Pue), known as a phytoestrogen, has salient bioactivities and is promising against cardiovascular diseases. This article summarizes the underlying molecular mechanisms of Pue in treating cardiovascular diseases, especially regulating the intracellular signal transduction, influencing ion channels, modulating the expression of microRNA, and impacting on the autophagy, which are mainly involved in the inflammatory signaling pathways, fatty acid/lipid metabolism, oxidative stress, apoptosis, and the like. The protective effect of Pue against cardiovascular diseases mainly involves attenuating the myocardial injury and decreasing the myocardial fibrosis, improving the myocardial ischemia/reperfusion injury, as well as inhibiting the myocardial hypertrophy and atherosclerosis. The molecular mechanisms of Pue’s cardiovascular protective effects for the first time and comment on the state-of-the-art research methods and principles of Pue’s regulation of small molecules were reviewed, so as to provide the rationale for its basic research and clinical applications. |
format | Online Article Text |
id | pubmed-9476793 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-94767932022-09-16 Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go Qin, Weida Guo, Jianghong Gou, Wenfeng Wu, Shaohua Guo, Na Zhao, Yuping Hou, Wenbin Chin Herb Med Review Puerarin (Pue), known as a phytoestrogen, has salient bioactivities and is promising against cardiovascular diseases. This article summarizes the underlying molecular mechanisms of Pue in treating cardiovascular diseases, especially regulating the intracellular signal transduction, influencing ion channels, modulating the expression of microRNA, and impacting on the autophagy, which are mainly involved in the inflammatory signaling pathways, fatty acid/lipid metabolism, oxidative stress, apoptosis, and the like. The protective effect of Pue against cardiovascular diseases mainly involves attenuating the myocardial injury and decreasing the myocardial fibrosis, improving the myocardial ischemia/reperfusion injury, as well as inhibiting the myocardial hypertrophy and atherosclerosis. The molecular mechanisms of Pue’s cardiovascular protective effects for the first time and comment on the state-of-the-art research methods and principles of Pue’s regulation of small molecules were reviewed, so as to provide the rationale for its basic research and clinical applications. Elsevier 2022-03-23 /pmc/articles/PMC9476793/ /pubmed/36117660 http://dx.doi.org/10.1016/j.chmed.2021.12.003 Text en © 2022 Tianjin Press of Chinese Herbal Medicines. Published by ELSEVIER B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review Qin, Weida Guo, Jianghong Gou, Wenfeng Wu, Shaohua Guo, Na Zhao, Yuping Hou, Wenbin Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go |
title | Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go |
title_full | Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go |
title_fullStr | Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go |
title_full_unstemmed | Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go |
title_short | Molecular mechanisms of isoflavone puerarin against cardiovascular diseases: What we know and where we go |
title_sort | molecular mechanisms of isoflavone puerarin against cardiovascular diseases: what we know and where we go |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9476793/ https://www.ncbi.nlm.nih.gov/pubmed/36117660 http://dx.doi.org/10.1016/j.chmed.2021.12.003 |
work_keys_str_mv | AT qinweida molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego AT guojianghong molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego AT gouwenfeng molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego AT wushaohua molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego AT guona molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego AT zhaoyuping molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego AT houwenbin molecularmechanismsofisoflavonepuerarinagainstcardiovasculardiseaseswhatweknowandwherewego |